(1 - 4 von 4
)
BioVentrix Announces Ralph Stephan von Bardeleben, MD ...au.news.yahoo.com › bioventrix-a...
au.news.yahoo.com
BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial. Business Wire
sortiert nach Relevanz / Datum